{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:00:15Z","timestamp":1793685615318,"version":"4.5.1"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Fatigue in Parkinson\u2019s disease (PD) is a highly prevalent and disabling non-motor symptom, often manifesting early and worsening over the disease course. Despite its significant impact on quality of life, fatigue remains underrecognized and poorly managed in clinical practice. It is a complex, multidimensional syndrome encompassing cognitive, emotional, and physical components. Its pathophysiology is multifactorial, involving disrupted dopaminergic, serotonergic, and glutamatergic signaling across fronto-striatal and limbic circuits. Fatigue frequently overlaps with neuropsychiatric symptoms such as apathy, depression, anxiety, and cognitive impairment, complicating both diagnosis and treatment. Although these conditions are clinically distinct, they share overlapping neural substrates and may influence each other\u2019s presentation and severity. Currently available therapeutic options for PD-related fatigue are limited, with rasagiline considered only \u201cpossibly useful,\u201d and most other pharmacologic and non-pharmacological strategies lacking rigorous evidence. This narrative review is based on a non-systematic PubMed literature search of peer-reviewed articles in English up to April 2025, with additional relevant studies identified through reference lists. It examines the clinical and neurobiological intersections between fatigue and neuropsychiatric symptoms in PD, highlighting key diagnostic challenges, treatment limitations, and future directions. Standardizing terminology, dissecting fatigue from overlapping neuropsychiatric symptoms, identifying reliable biomarkers, and conducting well-designed, mechanism-based clinical trials are essential next steps to redefine fatigue as a measurable and treatable symptom in PD.<\/jats:p>","DOI":"10.3389\/fneur.2025.1670644","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:55:12Z","timestamp":1761317712000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Fatigue and neuropsychiatric symptoms in Parkinson\u2019s disease: a narrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Lidia","family":"Bojtos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Rodr\u00edguez-Antig\u00fcedad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00fcl","family":"Mart\u00ednez-Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1212\/WNL.43.10.2016","article-title":"Fatigue in Parkinson\u2019s disease","volume":"43","author":"Friedman","year":"1993","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"15025-","DOI":"10.1038\/npjparkd.2015.25","article-title":"Fatigue in Parkinson\u2019s disease: report from a mutidisciplinary symposium","volume":"2","author":"Friedman","year":"2016","journal-title":"NPJ Parkinsons Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/mds.27461","article-title":"Fatigue in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"33","author":"Siciliano","year":"2018","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1212\/01.WNL.0000144277.06917.CC","article-title":"Is fatigue an independent and persistent symptom in patients with Parkinson disease?","volume":"63","author":"Alves","year":"2004","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/mds.1201","article-title":"Fatigue in Parkinson\u2019s disease: a nine-year follow-up","volume":"16","author":"Friedman","year":"2001","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3233\/JPD-202029","article-title":"Understanding the lexicon of fatigue in Parkinson\u2019s disease","volume":"10","author":"Mantri","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1212\/WNL.0b013e31827f07be","article-title":"Fatigue and fatigability in neurologic illnesses","volume":"80","author":"Kluger","year":"2013","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0022-510X(00)00411-1","article-title":"Fatigue and basal ganglia","volume":"179","author":"Chaudhuri","year":"2000","journal-title":"J Neurol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.parkreldis.2014.08.001","article-title":"Relationships among cognitive impairment, sleep, and fatigue in Parkinson\u2019s disease using the MDS-UPDRS","volume":"20","author":"Goldman","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","article-title":"Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease \u2013 associations with depression, fatigue, and cognitive impairment","volume":"33","author":"Lindqvist","year":"2013","journal-title":"Brain Behav Immun"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00702-016-1637-z","article-title":"Attention in Parkinson\u2019s disease with fatigue: evidence from the attention network test","volume":"124","author":"Pauletti","year":"2017","journal-title":"J Neural Transm"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/brain\/awq268","article-title":"Fatigue in Parkinson\u2019s disease is linked to striatal and limbic serotonergic dysfunction","volume":"133","author":"Pavese","year":"2010","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/mds.26597","article-title":"Randomized, controlled trial of acupuncture for fatigue in Parkinson\u2019s disease: acupuncture RCT for fatigue in PD","volume":"31","author":"Kluger","year":"2016","journal-title":"Mov Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/mds.26429","article-title":"Rasagiline for the symptomatic treatment of fatigue in Parkinson\u2019s disease","volume":"30","author":"Lim","year":"2015","journal-title":"Mov Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/mds.21656","article-title":"Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial","volume":"22","author":"Mendon\u00e7a","year":"2007","journal-title":"Mov Disord"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s disease\u2014an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"9614163","DOI":"10.1155\/2024\/9614163","article-title":"Mental fatigue in Parkinson\u2019s disease: systematic review and evaluation of self-reported fatigue scales","volume":"2024","author":"Chen","year":"2024","journal-title":"Parkinsons Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/mds.26511","article-title":"Parkinson\u2019s disease-related fatigue: a case definition and recommendations for clinical research","volume":"31","author":"Kluger","year":"2016","journal-title":"Mov Disord"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/mds.22989","article-title":"Fatigue rating scales critique and recommendations by the movement disorders society task force on rating scales for Parkinson\u2019s disease","volume":"25","author":"Friedman","year":"2010","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/ane.12282","article-title":"The associations between fatigue, apathy, and depression in Parkinson\u2019s disease","volume":"131","author":"Skorvanek","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"17562864251336903","DOI":"10.1177\/17562864251336903","article-title":"Approaches for treating neuropsychiatric symptoms in Parkinson\u2019s disease: a narrative review","volume":"18","author":"Rodr\u00edguez-Antig\u00fcedad","year":"2025","journal-title":"Ther Adv Neurol Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/mds.26650","article-title":"Functional connectivity underpinnings of fatigue in \u201cdrug-na\u00efve\u201d patients with Parkinson\u2019s disease","volume":"31","author":"Tessitore","year":"2016","journal-title":"Mov Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/00207454.2017.1381093","article-title":"Brain metabolic correlates of fatigue in Parkinson\u2019s disease: a PET study","volume":"128","author":"Zhang","year":"2018","journal-title":"Int J Neurosci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1155\/2000\/580683","article-title":"Fatigue in patients with Parkinson\u2019s disease","volume":"12","author":"Abe","year":"2000","journal-title":"Behav Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/hbm.23360","article-title":"Fatigue in Parkinson\u2019s disease: the contribution of cerebral metabolic changes","volume":"38","author":"Cho","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00702-017-1748-1","article-title":"Alterations in regional homogeneity of resting-state brain activity in fatigue of Parkinson\u2019s disease","volume":"124","author":"Li","year":"2017","journal-title":"J Neural Transm"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.14802\/jmd.24038","article-title":"Fatigue in Parkinson\u2019s disease is due to decreased efficiency of the frontal network: quantitative EEG analysis","volume":"17","author":"Kim","year":"2024","journal-title":"JMD"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00702-019-02130-9","article-title":"Neural and dopaminergic correlates of fatigue in Parkinson\u2019s disease","volume":"127","author":"Kang","year":"2020","journal-title":"J Neural Transm"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"101730","DOI":"10.1016\/j.nicl.2019.101730","article-title":"Structural brain correlates of fatigue in older adults with and without Parkinson\u2019s disease","volume":"22","author":"Kluger","year":"2019","journal-title":"NeuroImage Clin"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jocn.2020.07.004","article-title":"Global cortical atrophy may be associated with fatigue in patients with parkinson\u2019s disease","volume":"79","author":"Lu","year":"2020","journal-title":"J Clin Neurosci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2015.11.029","article-title":"Neuroimaging and clinical predictors of fatigue in Parkinson disease","volume":"23","author":"Chou","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/mds.30214","article-title":"Molecular-informed network analysis unveils fatigue-related functional connectivity in Parkinson\u2019s disease","volume":"40","author":"Di Vico","year":"2025","journal-title":"Mov Disord"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10072-014-1976-1","article-title":"The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil\/lymphocyte ratio in Parkinson\u2019s disease","volume":"36","author":"Ak\u0131l","year":"2015","journal-title":"Neurol Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/ane.12977","article-title":"Inflammation and fatigue in early, untreated Parkinson\u2019s disease","volume":"138","author":"Herlofson","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e47387","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson\u2019s disease \u2013 correlations with inflammatory cytokines in serum","volume":"7","author":"Lindqvist","year":"2012","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2016.09.030","article-title":"IL-6 serum levels are elevated in Parkinson\u2019s disease patients with fatigue compared to patients without fatigue","volume":"370","author":"Pereira","year":"2016","journal-title":"J Neurol Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"106844","DOI":"10.1016\/j.clineuro.2021.106844","article-title":"Possible inflammatory mechanisms and predictors of Parkinson\u2019s disease patients with fatigue (brief review)","volume":"208","author":"Wang","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"578222","DOI":"10.1016\/j.jneuroim.2023.578222","article-title":"Plasma TNF-\u03b1 and phosphorylated \u03b1-syn are associated with fatigue in patients with Parkinson\u2019s disease","volume":"385","author":"Wang","year":"2023","journal-title":"J Neuroimmunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"20647","DOI":"10.1038\/s41598-025-07735-7","article-title":"Affective and chronic fatigue symptoms are associated with serum neuronal damage markers in Parkinson\u2019s disease","volume":"15","author":"Al-Hakeim","year":"2025","journal-title":"Sci Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"17562864251324406","DOI":"10.1177\/17562864251324406","article-title":"The potential use of plasma NfL as a diagnostic and prognostic biomarker of fatigue in early Parkinson\u2019s disease","volume":"18","author":"Che","year":"2025","journal-title":"Ther Adv Neurol Disord"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mds.21316","article-title":"Characteristics of apathy in Parkinson\u2019s disease","volume":"22","author":"Dujardin","year":"2007","journal-title":"Mov Disord"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jnnp.2005.083113","article-title":"Neuropsychiatric symptoms in patients with Parkinson\u2019s disease and dementia: frequency, profile and associated care giver stress","volume":"78","author":"Aarsland","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","article-title":"Range of neuropsychiatric disturbances in patients with Parkinson\u2019s disease","volume":"67","author":"Aarsland","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/jnnp.73.6.636","article-title":"Apathy in Parkinson\u2019s disease","volume":"73","author":"Pluck","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12640-010-9196-9","article-title":"Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment","volume":"19","author":"Chase","year":"2011","journal-title":"Neurotox Res"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/mds.26208","article-title":"Apathy in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"30","author":"Den Brok","year":"2015","journal-title":"Mov Disord"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1176\/jnp.17.1.7","article-title":"Apathy: why care?","volume":"17","author":"Van Reekum","year":"2005","journal-title":"JNP"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/mds.26058","article-title":"Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms","volume":"29","author":"Dujardin","year":"2014","journal-title":"Mov Disord"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1037\/a0031531","article-title":"The association of apathy with central fatigue perception in patients with Parkinson\u2019s disease","volume":"127","author":"S\u00e1ez-Franc\u00e0s","year":"2013","journal-title":"Behav Neurosci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.parkreldis.2017.10.004","article-title":"Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients","volume":"45","author":"Siciliano","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp.2007.136895","article-title":"The nosological position of apathy in clinical practice","volume":"79","author":"Starkstein","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1038\/s41598-017-12457-6","article-title":"Separate neural representations of depression, anxiety and apathy in Parkinson\u2019s disease","volume":"7","author":"Dan","year":"2017","journal-title":"Sci Rep"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy of the prefrontal cortex\u2013basal ganglia circuits","volume":"16","author":"Levy","year":"2006","journal-title":"Cereb Cortex"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2020.08.019","article-title":"Predictors of fatigue severity in early, de novo Parkinson disease patients: a 1-year longitudinal study","volume":"79","author":"Siciliano","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","article-title":"Apathy in Parkinson\u2019s disease: clinical features, neural substrates, diagnosis, and treatment","volume":"14","author":"Pagonabarraga","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3233\/JPD-223223","article-title":"Apathy reflects extra-striatal dopaminergic degeneration in de novo Parkinson\u2019s disease","volume":"12","author":"Sampedro","year":"2022","journal-title":"JPD"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.parkreldis.2015.02.015","article-title":"Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson\u2019s disease patients","volume":"21","author":"Santangelo","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/aww162","article-title":"The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson\u2019s disease","volume":"139","author":"Maillet","year":"2016","journal-title":"Brain"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11910-017-0788-0","article-title":"Imaging the etiology of apathy, anxiety, and depression in Parkinson\u2019s disease: implication for treatment","volume":"17","author":"Thobois","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp-2013-306439","article-title":"Rivastigmine in apathetic but dementia and depression-free patients with Parkinson\u2019s disease: a double-blind, placebo-controlled, randomised clinical trial","volume":"85","author":"Devos","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"106237","DOI":"10.1016\/j.nbd.2023.106237","article-title":"Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson\u2019s disease","volume":"185","author":"Urso","year":"2023","journal-title":"Neurobiol Dis"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1517\/14656566.2011.587120","article-title":"Fatigue in Parkinson\u2019s disease","volume":"12","author":"Friedman","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/psyg.12302","article-title":"Fatigue in Parkinson\u2019s disease: concepts and clinical approach","volume":"18","author":"Nassif","year":"2018","journal-title":"Psychogeriatrics"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1468-1331.2012.03663.x","article-title":"Fatigue in early Parkinson\u2019s disease. Minor inconvenience or major distress? Euro J of","volume":"19","author":"Herlofson","year":"2012","journal-title":"Neurology"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/ene.15411","article-title":"Validation of new diagnostic criteria for fatigue in patients with Parkinson disease. Euro J of","volume":"29","author":"Siciliano","year":"2022","journal-title":"Neurology"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/1531-8257(199903)14:2<237::AID-MDS1006>3.0.CO;2-X","article-title":"Fatigue in patients with Parkinson\u2019s disease","volume":"14","author":"Karlsen","year":"1999","journal-title":"Mov Disord"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1212\/WNL.0000000000000587","article-title":"Prevalence of fatigue in Parkinson disease and its clinical correlates","volume":"83","author":"Stocchi","year":"2014","journal-title":"Neurology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000351779","article-title":"Influence of disease severity on fatigue in patients with Parkinson\u2019s disease is mainly mediated by symptoms of depression","volume":"70","author":"Van Dijk","year":"2013","journal-title":"Eur Neurol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijge.2016.05.011","article-title":"The relationship between fatigue and other non-motor symptoms in Parkinson\u2019s disease in Chinese population","volume":"11","author":"Ding","year":"2017","journal-title":"Int J Gerontol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/cns.12666","article-title":"Abnormal resting-state neural activity and connectivity of fatigue in Parkinson\u2019s disease","volume":"23","author":"Zhang","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3988\/jcn.2016.12.2.172","article-title":"Parkinson\u2019s disease with fatigue: clinical characteristics and potential mechanisms relevant to \u03b1-Synuclein oligomer","volume":"12","author":"Zuo","year":"2016","journal-title":"J Clin Neurol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.parkreldis.2015.07.007","article-title":"The association between fatigue and apathy in patients with either Parkinson\u2019s disease or multiple sclerosis","volume":"21","author":"Cochrane","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/jnnp.2008.159772","article-title":"Towards an understanding of fatigue in Parkinson disease","volume":"80","author":"Hagell","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/mds.26321","article-title":"Altered brain network centrality in depressed Parkinson\u2019s disease patients","volume":"30","author":"Lou","year":"2015","journal-title":"Mov Disord"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1038\/s41598-017-02127-y","article-title":"Aberrant intra- and internetwork functional connectivity in depressed Parkinson\u2019s disease","volume":"7","author":"Wei","year":"2017","journal-title":"Sci Rep"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ene.13002","article-title":"Depression, anxiety, and apathy in Parkinson\u2019s disease: insights from neuroimaging studies","volume":"23","author":"Wen","year":"2016","journal-title":"Eur J Neurol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/mds.23895","article-title":"Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson\u2019s disease","volume":"27","author":"Ballanger","year":"2012","journal-title":"Mov Disord"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-510X(99)00127-6","article-title":"The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson\u2019s disease","volume":"166","author":"Broussolle","year":"1999","journal-title":"J Neurol Sci"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.parkreldis.2012.05.022","article-title":"Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson\u2019s disease patients","volume":"18","author":"Erro","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00259-008-0979-7","article-title":"Monoamine transporter availability in Parkinson\u2019s disease patients with or without depression","volume":"36","author":"Hesse","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1111\/j.1460-9568.2007.05580.x","article-title":"Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson\u2019s disease","volume":"25","author":"Koerts","year":"2007","journal-title":"Eur J Neurosci"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.22158","article-title":"Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson\u2019s disease","volume":"23","author":"Rektorova","year":"2008","journal-title":"Mov Disord"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson\u2019s disease: predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain"},{"key":"ref87","first-page":"227","article-title":"Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson\u2019s disease","volume":"46","author":"Weintraub","year":"2005","journal-title":"J Nucl Med"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","article-title":"Olfactory bulb \u03b1-synucleinopathy has high specificity and sensitivity for Lewy body disorders","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/mds.26510","article-title":"Nonmotor features of Parkinson\u2019s disease subtypes","volume":"31","author":"Marras","year":"2016","journal-title":"Mov Disord"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","article-title":"Parkinson\u2019s: a syndrome rather than a disease?","volume":"124","author":"Titova","year":"2017","journal-title":"J Neural Transm"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/jcbfm.2012.60","article-title":"Heterogeneity of cholinergic denervation in Parkinson\u2019s disease without dementia","volume":"32","author":"Bohnen","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00702-019-02003-1","article-title":"Mild cognitive impairment in Parkinson\u2019s disease","volume":"126","author":"Martinez-Horta","year":"2019","journal-title":"J Neural Transm"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.parkreldis.2021.09.020","article-title":"The psychological correlates of fatigue in Parkinson\u2019s disease: contribution of maladaptive metacognitive beliefs","volume":"91","author":"Siciliano","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/brainsci14040397","article-title":"The impact of fatigue on sleep and other non-motor symptoms in Parkinson\u2019s disease","volume":"14","author":"Diaconu","year":"2024","journal-title":"Brain Sci"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mds.21240","article-title":"Fatigue in Parkinson\u2019s disease: a review","volume":"22","author":"Friedman","year":"2007","journal-title":"Mov Disord"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2017.02.005","article-title":"Is fatigue associated with cognitive dysfunction in early Parkinson\u2019s disease?","volume":"37","author":"Kluger","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson\u2019s disease (the ONSET PD study)","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov Disord"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1133705","DOI":"10.3389\/fnagi.2023.1133705","article-title":"Characteristics of fatigue in Parkinson\u2019s disease: a longitudinal cohort study","volume":"15","author":"Zhou","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1038\/s41598-022-15630-8","article-title":"Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson\u2019s disease","volume":"12","author":"Kwon","year":"2022","journal-title":"Sci Rep"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.nbd.2012.03.029","article-title":"Cognitive impairment and dementia in Parkinson\u2019s disease","volume":"46","author":"Pagonabarraga","year":"2012","journal-title":"Neurobiol Dis"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000498883","article-title":"Effects of cognitive performance and affective status on fatigue in Parkinson\u2019s disease","volume":"9","author":"Spirgi","year":"2019","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ana.24859","article-title":"Serotonin transporter in Parkinson\u2019s disease: a meta-analysis of positron emission tomography studies","volume":"81","author":"Pagano","year":"2017","journal-title":"Ann Neurol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/ana.25236","article-title":"Serotonin, \u03b2-amyloid, and cognition in Parkinson disease","volume":"83","author":"Kotagal","year":"2018","journal-title":"Ann Neurol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/brain\/awn054","article-title":"Cognitive deficits and striato-frontal dopamine release in Parkinson\u2019s disease","volume":"131","author":"Sawamoto","year":"2008","journal-title":"Brain"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.clinph.2019.01.017","article-title":"Central fatigue and attentional processing in Parkinson\u2019s disease: an event-related potentials study","volume":"130","author":"Pauletti","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1176\/appi.psy.51.6.474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.parkreldis.2022.05.020","article-title":"Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson\u2019s disease","volume":"105","author":"Pagonabarraga","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00702-023-02704-8","article-title":"The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with Parkinson\u2019s disease","volume":"131","author":"Zhao","year":"2024","journal-title":"J Neural Transm (Vienna)"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ene.13161","article-title":"Fatigue in early Parkinson\u2019s disease: the Norwegian ParkWest study","volume":"24","author":"Ongre","year":"2017","journal-title":"Eur J Neurol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1212\/WNL.0000000000000801","article-title":"Course of psychiatric symptoms and global cognition in early Parkinson disease","volume":"83","author":"de la Riva","year":"2014","journal-title":"Neurology"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/14737175.2020.1752669","article-title":"Identifying and responding to fatigue and apathy in Parkinson\u2019s disease: a review of current practice","volume":"20","author":"Lazcano-Ocampo","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jns.2012.07.015","article-title":"The role of the dopaminergic system in mood, motivation and cognition in Parkinson\u2019s disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate","volume":"320","author":"Drijgers","year":"2012","journal-title":"J Neurol Sci"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/jnnp.2005.065870","article-title":"Modafinil for daytime somnolence in Parkinson\u2019s disease: double blind, placebo controlled parallel trial","volume":"76","author":"Ondo","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1212\/WNL.0b013e318263570d","article-title":"Caffeine for treatment of Parkinson disease: a randomized controlled trial","volume":"79","author":"Postuma","year":"2012","journal-title":"Neurology"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson\u2019s disease \u2013 a randomized study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1474-4422(11)70073-4","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes","volume":"10","author":"Rascol","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/mds.10505","article-title":"Levodopa improves physical fatigue in Parkinson\u2019s disease: a double-blind, placebo-controlled, crossover study","volume":"18","author":"Lou","year":"2003","journal-title":"Mov Disord"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/mds.26731","article-title":"The hidden sister of motor fluctuations in Parkinson\u2019s disease: a review on nonmotor fluctuations","volume":"31","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2016","journal-title":"Mov Disord"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0b013e318285c0ed","article-title":"Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications","volume":"80","author":"Storch","year":"2013","journal-title":"Neurology"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF03033378","article-title":"Striatal glutamatergic mechanisms and extrapyramidal movement disorders","volume":"5","author":"Chase","year":"2003","journal-title":"Neurotox Res"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/JPD-191765","article-title":"Long-term efficacy of safinamide on symptoms severity and quality of life in fluctuating Parkinson\u2019s disease patients","volume":"10","author":"Cattaneo","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10072-021-05324-w","article-title":"Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson\u2019s disease patients: a prospective longitudinal study","volume":"43","author":"De Micco","year":"2022","journal-title":"Neurol Sci"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12325-018-0687-z","article-title":"Long-term efficacy of safinamide on Parkinson\u2019s disease chronic pain","volume":"35","author":"Cattaneo","year":"2018","journal-title":"Adv Ther"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"866502","DOI":"10.3389\/fneur.2022.866502","article-title":"A randomized clinical trial to evaluate the effects of safinamide on apathetic non-demented patients with Parkinson\u2019s disease","volume":"13","author":"Kulisevsky","year":"2022","journal-title":"Front Neurol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/brainsci11030316","article-title":"Safinamide improves non-motor symptoms burden in Parkinson\u2019s disease: an open-label prospective study","volume":"11","author":"Santos Garc\u00eda","year":"2021","journal-title":"Brain Sci"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JPD-225116","article-title":"Physical exercise as a potential treatment for fatigue in Parkinson\u2019s disease? A systematic review and Meta-analysis of pharmacological and non-pharmacological interventions","volume":"13","author":"Folkerts","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00702-023-02726-2","article-title":"Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson\u2019s disease: a pilot study","volume":"131","author":"Simonetta","year":"2024","journal-title":"J Neural Transm"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/08919887231163291","article-title":"Pharmacological and behavioral interventions for fatigue in Parkinson\u2019s disease: a meta-analysis of randomized controlled trials","volume":"36","author":"Jiang","year":"2023","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1212\/01.wnl.0000324862.29733.69","article-title":"Fatigue in levodopa-na\u00efve subjects with Parkinson disease","volume":"71","author":"Schifitto","year":"2008","journal-title":"Neurology"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/mds.26067","article-title":"EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson\u2019s disease","volume":"30","author":"Martinez-Martin","year":"2015","journal-title":"Mov Disord"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/mds.27626","article-title":"EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson\u2019s disease","volume":"34","author":"Dafsari","year":"2019","journal-title":"Mov Disord"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.parkreldis.2013.02.018","article-title":"Rotigotine and specific non-motor symptoms of Parkinson\u2019s disease: post hoc analysis of RECOVER","volume":"19","author":"Ray Chaudhuri","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/WNF.0b013e3181aa916a","article-title":"Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study","volume":"32","author":"Lou","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.parkreldis.2010.12.003","article-title":"Memantine for non-motor features of Parkinson\u2019s disease: a double-blind placebo controlled exploratory pilot trial","volume":"17","author":"Ondo","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8624986","article-title":"Effects of vestibular rehabilitation on fatigue and activities of daily living in people with Parkinson\u2019s disease: a pilot randomized controlled trial study","volume":"10","author":"Abasi","year":"2020","journal-title":"Parkinsons Dis"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.1042","article-title":"Exacerbated physical fatigue and mental fatigue in Parkinson\u2019s disease","volume":"16","author":"Lou","year":"2001","journal-title":"Movement Disorders"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1670644\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:55:14Z","timestamp":1761317714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1670644\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":137,"alternative-id":["10.3389\/fneur.2025.1670644"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1670644","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"article-number":"1670644"}}